Meg Edwards

SmartAnalyst

SmartAnalyst is focused on supporting Bio-Pharma Innovation, with a mission to drive pipeline and portfolio value for global pharmaceutical and biotech companies. We provide Consulting services, Health Economic and Real World Evidence solutions, and Insights that are compelling, strategic and actionable. Founded in 2000 and a part of the UDG Healthcare group since 2018. Our three pillars of Strategy, Value and Insights are aimed at identifying and commercializing novel innovative therapies to improve patient outcomes and garner market success, providing compelling clinical and cost benefit evidence to secure advantageous reimbursement and access to patients, and data driven insights into future market dynamics to develop forward looking strategies for clinical differentiation and success. We have worked across all major therapeutic areas including oncology, immunology, neurosciences, cardiovascular and rare diseases. Oncology is the cornerstone of our consulting business.